STOCK TITAN

Erasca (NASDAQ: ERAS) insider files to sell 120,000 common shares

Filing Impact
(Neutral)
Filing Sentiment
(Neutral)
Form Type
144

Rhea-AI Filing Summary

Erasca, Inc. has a holder planning to sell 120,000 shares of its common stock under Rule 144. The shares are to be sold through Merrill Lynch in Rancho Santa Fe, California, with an aggregate market value of $670,809.15 based on the price used in the notice. The planned sale date is listed as January 7, 2026, on the NASDAQ market.

The 120,000 common shares were acquired on January 7, 2026 through a stock option transaction with Erasca, Inc., with cash listed as the form of payment. The notice also reports that 283,711,805 shares of Erasca common stock were outstanding, providing context for the size of the planned sale.

Positive

  • None.

Negative

  • None.

144: Filer Information

144: Issuer Information

144: Securities Information



Furnish the following information with respect to the acquisition of the securities to be sold and with respect to the payment of all or any part of the purchase price or other consideration therefor:

144: Securities To Be Sold


* If the securities were purchased and full payment therefor was not made in cash at the time of purchase, explain in the table or in a note thereto the nature of the consideration given. If the consideration consisted of any note or other obligation, or if payment was made in installments describe the arrangement and state when the note or other obligation was discharged in full or the last installment paid.



Furnish the following information as to all securities of the issuer sold during the past 3 months by the person for whose account the securities are to be sold.

144: Securities Sold During The Past 3 Months

144: Remarks and Signature

FAQ

What does the Form 144 filing for ERAS disclose?

The filing discloses that a holder of Erasca, Inc. common stock plans to sell 120,000 shares under Rule 144 through a broker.

How many Erasca (ERAS) shares are planned to be sold and on what exchange?

The notice covers the planned sale of 120,000 common shares of Erasca, Inc. on the NASDAQ exchange.

What is the reported market value of the ERAS shares in this Form 144?

The aggregate market value of the 120,000 Erasca, Inc. shares listed in the notice is $670,809.15.

When were the ERAS shares to be sold according to the notice?

The filing lists an approximate date of sale of January 7, 2026 for the 120,000 Erasca, Inc. common shares.

How were the Erasca (ERAS) shares being sold acquired?

The 120,000 Erasca, Inc. common shares were acquired on January 7, 2026 via a stock option transaction from Erasca, Inc., with cash as the form of payment.

How many Erasca (ERAS) shares were outstanding according to this filing?

The notice states that 283,711,805 common shares of Erasca, Inc. were outstanding, giving context for the planned 120,000-share sale.

Which broker is handling the planned ERAS share sale in this Form 144?

The planned sale of 120,000 Erasca, Inc. common shares is listed as being through Merrill Lynch at an address in Rancho Santa Fe, California.
Erasca, Inc.

NASDAQ:ERAS

ERAS Rankings

ERAS Latest News

ERAS Latest SEC Filings

ERAS Stock Data

2.73B
227.86M
11.68%
81.93%
6.6%
Biotechnology
Pharmaceutical Preparations
Link
United States
SAN DIEGO